Neurodevelopmental conditions and aging: report on the Atlanta Study Group Charrette on Neurodevelopmental Conditions

Matthew P Janicki1, C Michael Henderson, I Leslie Rubin

  • 1Department of Human Development and Disability, University of Illinois at Chicago, Chicago, IL 60608, USA. mjanicki@uic.edu

Insights

Research on aging with neurodevelopmental conditions like autism and Down syndrome is limited. More evidence-based studies are needed to understand long-term health effects and improve care for adults with these lifelong disabilities.

Area of Science:

  • Neurodevelopmental Disorders
  • Gerontology
  • Public Health

Background:

  • The Neurodevelopmental Conditions Study Group convened to address the aging process in individuals with developmental disabilities.
  • Existing research on lifespan changes in conditions like cerebral palsy and Down syndrome is insufficient for most neurodevelopmental disorders.

Purpose of the Study:

  • To examine current knowledge on aging-related effects in neurodevelopmental conditions.
  • To identify gaps in research regarding long-term health trajectories and supportive environments.

Main Methods:

  • A charrette (intensive working meeting) was held, summarizing proceedings from a conference on aging with developmental disabilities.
  • Discussions focused on conditions including autism, cerebral palsy, Down syndrome, fragile X syndrome, Prader-Willi syndrome, spina bifida, and Williams syndrome.

Main Results:

  • A significant lack of evidence-based research exists concerning the long-term effects of aging on adults with most neurodevelopmental conditions.
  • Published data is more available for cerebral palsy and Down syndrome, but still requires further confirmation.

Conclusions:

  • Additional research and clinical investigation are crucial for understanding maturation and aging in adults with neurodevelopmental conditions.
  • Recommendations include identifying age-related medical disorders, determining comparative prevalence, understanding risk factors, promoting surveillance and screening, and disseminating health information.

Related Concept Videos

Aging01:26

Aging

Aging is a complex biological phenomenon influenced by various processes that affect cellular and systemic functions. Several prominent theories attempt to explain its mechanisms, highlighting cellular limitations, oxidative damage, and hormonal changes as central factors in aging.
Cellular Clock Theory
The cellular clock theory posits that the human lifespan is closely tied to the finite capacity of cells to divide, a phenomenon governed by telomeres, which are protective caps at the ends of...
Cognitive Development During Adulthood01:30

Cognitive Development During Adulthood

Cognitive development continues throughout adulthood, undergoing significant shifts across early, middle, and late stages. Individual transition occurs from adolescent idealism to pragmatic and adaptable thinking in early adulthood. During this period, individuals learn to integrate personal beliefs with the recognition that other perspectives are equally valid. Exposure to the complexities of modern society, diverse experiences, and higher education contribute to this adaptive thought process,...
Alzheimer Disease l: Introduction01:29

Alzheimer Disease l: Introduction

Alzheimer disease is a chronic, progressive, and irreversible neurodegenerative disorder and the most common cause of dementia in older adults. It leads to gradual neuronal loss, causing cognitive decline, behavioral changes, and loss of functional independence.Risk Factors and EtiologyThe disease is multifactorial. Age is the strongest risk factor, with prevalence doubling every 5 years after age 65. Genetic factors include mutations in genes such as APP, PSEN1, and PSEN2, which are associated...
Alzheimer's Disease: Overview01:26

Alzheimer's Disease: Overview

Alzheimer's Disease (AD) is a continually advancing neurodegenerative disorder, distinguished by escalating memory loss, cognitive dysfunction, and dementia. The disease unfolds in three stages: preclinical, mild cognitive impairment (MCI), and dementia. Its onset is insidious, and the progression gradual, with the cause not well explained by other disorders.
The clinical diagnosis of AD hinges on the presence of memory and other cognitive impairments. Biomarkers, such as changes in Aβ and tau...
The Effect of Aging on Tissues01:19

The Effect of Aging on Tissues

Several body functions deteriorate with age. The external signs of aging are easily identifiable. For example, the skin becomes dry, less elastic, and thins out, forming wrinkles. The skin of the face begins to appear looser due to a decrease in the levels of elastic and collagen fibers in the connective tissue. Additionally, melanin production in the hair follicle decreases with age, resulting in gray hair. Moreover, the senses of sight and hearing decline, so glasses and hearing aids may...
Alzheimer's Disease: Treatment01:22

Alzheimer's Disease: Treatment

Alzheimer's Disease (AD), a neurodegenerative disorder, is pathologically identified by amyloid plaques and neurofibrillary tangles composed of tau protein. AD pharmacotherapy aims to manage cognitive symptoms, delay disease progression, and treat behavioral symptoms. The treatment is primarily symptomatic and palliative, with no definitive disease-modifying therapy available. Cholinesterase inhibitors, including donepezil (Aricept), rivastigmine (Exelon), and galantamine (Razadyne), are...